S&P assigns ‘A+’ rating to Salem Health’s bonds

S&P Global Ratings has assigned an “A+” long-term rating to Salem (Ore.) Health’s series 2016A bonds and affirmed the existing “A+” long-term and underlying ratings on Salem Health.

Advertisement

“The rating assignment and affirmation reflects maintenance of a very strong financial profile combined with a strong enterprise profile,” said S&P analyst Martin Arrick. “The rating also reflects the sharp reduction in pro forma maximum annual debt service (MADS) and improved MADS coverage as a result of this refunding transaction.”

The outlook is stable.

More articles on healthcare finance:
Advisory Board: Hospital system pricing strategy affects bottom line by up to $40M
3 essential skills hospitals need in RCM leadership
S&P assigns ‘AA-‘ rating to University of Chicago Medical Center’s bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.